Profil
Andy Crew worked as a Senior Director at OSI Pharmaceuticals and Astellas Pharmaceuticals SA from 2002 to 2013.
He was also a Principal Scientist at Knoll Pharmaceutical Co. from 1990 to 1996.
Later, he worked as a Senior Vice President-Chemistry at Arvinas Operations, Inc. and Arvinas, Inc. from an unknown date to 2019.
Dr. Crew holds a doctorate degree from The University of Liverpool.
Ehemalige bekannte Positionen von Andy Crew
| Unternehmen | Position | Ende |
|---|---|---|
| OSI PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2013 |
Astellas Pharmaceuticals SA | Direktor/Vorstandsmitglied | 01.01.2013 |
Knoll Pharmaceutical Co. | Corporate Officer/Principal | 01.01.1996 |
| ARVINAS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Corporate Officer/Principal | - |
Ausbildung von Andy Crew
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Knoll Pharmaceutical Co. | |
Astellas Pharmaceuticals SA | |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
















